Open innovation arenas in life science
| Reference number | |
| Coordinator | Göteborgs Universitet - Företagsekonomiska institutionen |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | November 2016 - November 2017 |
| Status | Completed |
Important results from the project
The project´s goal was to create knowledge about challenges and opportunities related to the establishment of open innovation arenas in life science. The research project has followed the emergence of AstraZeneca´s BioVentureHub and a so-called "spin-out" project where internal projects are transferred to new ventures funded by external investors. Driving forces, activities and challenges have been documented and analyzed.
Expected long term effects
AstraZeneca has now successfully run BioVentureHub for almost four years and the research project has closely followed the initiative from idea to implementation. Both BioVentureHub and the “spin-out project” have been documented and analyzed. The knowledge and experiences have been complied into a report to Vinnova, as well as in various research papers. The diffusion of knowledge about open innovation in life science and in large corporations will continue also after the project ends.
Approach and implementation
The study of AZ BioVentureHub has been funded by two subsequent research projects. In total, we have conducted 75 interviews with 55 individuals, linked to AstraZeneca, hub companies, the spin-out initiative and other life science actors in the Swedish innovation system. A survey has also been conducted, where the hub companies’ development has been analyzed. In addition, a number of feedback workshops have been held with participating organizations.